Nelson Barayuga, MT/CT(ASCP), MBA, is lead medical technologist, Syosset Hospital (North Shore Long Island Jewish Health System), and cytotechnologist.
Join him on Monday, Nov. 14, at noon Eastern for an important discussion for any lab manager and stakeholder in the cytology lab.
The Pap test is one of the most significant developments in cancer screening. When considering the latest trends in cytology, cellular morphology and structural characteristics no longer singularly define pathology. Other factors such as automation and molecular diagnostics help contribute to a meaningful diagnosis.
These advances have brought about changes in the way cytotechnologists do their work and the outlook of the profession as a whole. With new automated screening technologies and molecular assays to confirm findings, the cytology lab is seeing enhanced efficiency, and increased reliability and accuracy of results.